186 related articles for article (PubMed ID: 28647776)
1. Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up.
Ogawa Y; Ikeda K; Watanabe C; Kamei Y; Tokunaga S; Tsuboguchi Y; Inoue T; Fukushima H; Ichiki M
Surg Today; 2018 Jan; 48(1):87-94. PubMed ID: 28647776
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H
Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
Galimberti V; Ribeiro Fontana SK; Maisonneuve P; Steccanella F; Vento AR; Intra M; Naninato P; Caldarella P; Iorfida M; Colleoni M; Viale G; Grana CM; Rotmensz N; Luini A
Eur J Surg Oncol; 2016 Mar; 42(3):361-8. PubMed ID: 26746091
[TBL] [Abstract][Full Text] [Related]
4. Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up.
Kahler-Ribeiro-Fontana S; Pagan E; Magnoni F; Vicini E; Morigi C; Corso G; Intra M; Canegallo F; Ratini S; Leonardi MC; La Rocca E; Bagnardi V; Montagna E; Colleoni M; Viale G; Bottiglieri L; Grana CM; Biasuz JV; Veronesi P; Galimberti V
Eur J Surg Oncol; 2021 Apr; 47(4):804-812. PubMed ID: 33092968
[TBL] [Abstract][Full Text] [Related]
5. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.
Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA
Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709
[TBL] [Abstract][Full Text] [Related]
6. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
[TBL] [Abstract][Full Text] [Related]
7. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL
Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912
[TBL] [Abstract][Full Text] [Related]
8. Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.
van der Heiden-van der Loo M; de Munck L; Sonke GS; van Dalen T; van Diest PJ; van den Bongard HJ; Peeters PH; Rutgers EJ
Eur J Cancer; 2015 May; 51(8):915-21. PubMed ID: 25857549
[TBL] [Abstract][Full Text] [Related]
9. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
[TBL] [Abstract][Full Text] [Related]
10. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study.
Maaskant-Braat AJ; Roumen RM; Voogd AC; Pijpers R; Luiten EJ; Rutgers EJ; Nieuwenhuijzen GA
Ann Surg Oncol; 2013 Feb; 20(2):620-6. PubMed ID: 22941173
[TBL] [Abstract][Full Text] [Related]
11. Improving the Success Rate of Repeat Sentinel Node Biopsy in Recurrent Breast Cancer.
Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Roumen RM; Luiten EJ; Rutgers EJ; Wyndaele D; Rutten HJ; Nieuwenhuijzen GA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S529-35. PubMed ID: 26259754
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer.
Trocha SD; Giuliano AE
Surg Oncol; 2003 Dec; 12(4):271-6. PubMed ID: 14998567
[TBL] [Abstract][Full Text] [Related]
13. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
Soni NK; Spillane AJ
ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan.
Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S
Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462
[TBL] [Abstract][Full Text] [Related]
15. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G
Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
[TBL] [Abstract][Full Text] [Related]
18. Observational study of blue dye-assisted four-node sampling for axillary staging in early breast cancer.
Narui K; Ishikawa T; Kito A; Shimizu D; Chishima T; Momiyama N; Ichikawa Y; Sasaki T; Nozawa A; Inayama Y; Shimada H; Endo I
Eur J Surg Oncol; 2010 Aug; 36(8):731-6. PubMed ID: 20609549
[TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
